Model provides better clinical results and has potential to save billions nationwide, says chief innovation officer. Susan Morse, Associate Editor Hackensack Meridian Health in New Jersey has found a way to deliver on the promise of precision medicine and population health for better clinical and financial outcomes. Hackensack’s Andrew Pecora MD, believes the success of Read More …
Month: May 2017
Colorado Springs lab firm recovers from near-shutdown to double in size
Colorado Springs lab firm recovers from near-shutdown to double in size By: Wayne Heilman May 20, 2017 Updated: May 20, 2017 at 2:51 pm Pyxant Labs Inc. was nearly at the point of shutting down when CEO Maurice Gaubatz instead shifted to a new strategy that has helped the Colorado Springs-based pharmaceutical testing company to Read More …
We’re missing the point with precision medicine
By JULIET PRESTON With all this talk of moonshot missions and initiatives, it’s not surprising that the healthcare industry often overlooks one of the greatest barriers to implementing precision medicine. During a Thursday panel at the MedCity INVEST conference in Chicago, Manoja Lecamwasam of California-based Dignity Health reminded the audience what it’s all about. As Read More …
The vision of precision medicine takes shape
Precision medicine is a market catching fire. The growth is so rapid that analysts have projected spending in the field will approach $87 annually within six years. With more healthcare organizations investing in the technologies, expectations are growing for significant advances in improved treatment and early detection of disease. The HIMSS Precision Medicine Summit Read More …
Precision medicine improves treatment outcomes for some pancreatic cancer patients
UNIVERSITY OF PITTSBURGH SCHOOLS OF THE HEALTH SCIENCES PUBLIC RELEASE: 9-MAY-2017 University of Pittsburgh and UPMC researchers are paving the way for genome-targeted treatments in pancreatic cancer, an especially deadly form of cancer with few existing therapeutic options, according to a pair of recent studies. The first study used genomic profiling to identify targeted therapies that Read More …
US can’t afford to be left behind in precision medicine ‘gold rush’
BY JOHN SOTOS, M.D., STEVE ROSENBERG, AND MORTEN SOGAARD, PH.D., OPINION CONTRIBUTORS – 05/05/17 08:00 AM EDT Precision medicine is the next step in the medical profession’s 2,500-year quest to individualize medical treatments — and one of the most significant. Often called the next “space race” because of the immense technological advances required to make Read More …